The Effectiveness of the Android Application as a Pharmaceutical Education Tool in Hypertensive Patients
The Influence of Android Application as a Pharmaceutical Education Tool on Knowledge, Adherence, Clinical Outcome and Quality of Life of Hypertension Prolanis Patients: A Pilot Study
1 other identifier
interventional
100
1 country
1
Brief Summary
Hypertension is a worldwide public health challenge due to its high prevalence and along with increased risk of complications of other diseases that are more dangerous if not managed properly. An estimated 1.4 billion people worldwide have high blood pressure, but only 14% can control it. Knowledge of hypertension in patients with hypertension can prevent complications through hypertension treatment. Increasing knowledge can be done by providing education in the form of counseling by pharmacists to hypertensive patients. Counseling activities carried out by pharmacists can be supported by a technological approach. One of the uses in smartphone technology is by creating an android-based mobile application that can be developed to support pharmaceutical care. Education conducted by pharmacists can increase knowledge that will affect hypertension treatment adherence, and this education can also improve blood pressure control so that it can improve the quality of life. The purpose of this study is to analyze the influence of the android application as a standard pharmacist education tool on knowledge as well as adherence and therapeutic outcomes of hypertensive patients, and quality of life related to the health of hypertensive patients compared to just providing standard education by pharmacists to hypertensive patients at the Primary Health Care. The method used in this study is a Quasi-Experimental with Pretest - Posttest Control Group Design. Samples were obtained by purposive sampling method at the selected Primary Health Care as the intervention group and the selected Primary Health Care as the control group. Pharmacist provides education to intervention groups with android applications as counseling aids and in control groups only standard counseling is provided. Pre-test data collection was done by taking primary and secondary data of patients at the first meeting and post-test data collection was taken prospectively through face-to-face interviews and questionnaires on hypertensive patients participants for three months by observing the influence of android applications as counseling aids on knowledge of hypertensive diseases, adherence to antihypertensive treatment, outcome therapy and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Mar 2023
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2023
CompletedFirst Posted
Study publicly available on registry
February 15, 2023
CompletedStudy Start
First participant enrolled
March 16, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 16, 2023
CompletedAugust 15, 2023
July 1, 2023
3 months
February 5, 2023
August 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Knowledge about hypertension
Measured by Hypertension Knowledge-Level Scale (HK-LS) questionnaires
At day 90 after treatment
Adherence to antihypertensive treatment
Measurement by Medication Adherence Report Scale (MARS) questionnaires
At day 90 after treatment
Secondary Outcomes (2)
Blood pressure
90 days
Quality of life related to the health
90 days
Study Arms (2)
Intervention group
EXPERIMENTALPharmacy Education with Android Application as a Tool Conducted for Three Months in Hypertensive Patients to Improve Knowledge, Adherence, Outcome Therapy and Quality of Life
Pharmacy education
ACTIVE COMPARATORPharmacy education in hypertensive patients
Interventions
Pharmacy education in hypertensive patients
Eligibility Criteria
You may qualify if:
- Patients aged ≥ 18 years, male and female who are willing to be respondents.
- Patients diagnosed with hypertension or currently taking ≥ 1 antihypertensive drug.
- Hypertension patients who carry out routine control and receive anti-hypertensive drugs for at least 3 months at the Health Center.
- Not illiterate and owns a smartphone.
- Patients who are willing to participate in the study by signing an informed consent.
You may not qualify if:
- Physical and mental disabilities such as deaf, blind, and psychiatric disorders.
- The patient is pregnant
- Currently taking hormonal drugs and other routine drugs such as TB, HIV and AIDS drugs.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Centers
Bandar Lampung, Lampung, Indonesia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Abdul K Tasib, S.Si., Apt.
Faculty of Pharmacy Universitas Padjadjaran Bandung
- PRINCIPAL INVESTIGATOR
Eli Halimah, Dr.M.Si.Apt.
Faculty of Pharmacy Universitas Padjadjaran Bandung
- PRINCIPAL INVESTIGATOR
Irma M Puspitasari, Prof.MT.Ph.D
Faculty of Pharmacy Universitas Padjadjaran Bandung
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 5, 2023
First Posted
February 15, 2023
Study Start
March 16, 2023
Primary Completion
June 16, 2023
Study Completion
June 16, 2023
Last Updated
August 15, 2023
Record last verified: 2023-07